LANSING, Mich., Jan. 26, 2009 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB) today announced the availability of a new research report on the Company. The report, issued by Emerging Growth Research, LLP provides an overview of the Company and updates investors on recent activities.
"We have been making significant progress in the laboratory toward the aim of producing new spider silk based fibers and textiles. We recently announced the scientific team successfully achieved the activation of florescent gene marker sequences, which the researchers incorporated into spider silk DNA packets. This was a major milestone for the Company," commented Kim K. Thompson, CEO of Kraig Biocraft. "The new and updated research report provides an excellent overview of the methodologies we are employing to address this potentially lucrative market."
Please visit www.wallstreetreportonline.com/KBLB to view or download the report. For more information on Kraig Biocraft Laboratories, and to hear an audio interview with Kraig's CEO, please visit the Company's web site: http://www.KraigLabs.com
Statements in this press release about the company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
The Kraig Biocraft Laboratories, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4817